We are excited to be participating in Canaccord Genuity’s 44th Annual Growth Conference, hosted in Boston! Tomorrow, August 14th, our CEO, Paulash Mohsen, will be presenting at 11:30 AM EST.
Vesigen Therapeutics, Inc.
生物技术研究
Cambridge,Massachusetts 4,670 位关注者
Delivering intracellular therapeutics with ARMMed microvesicles
关于我们
Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets. Our team is committed to leveraging ARMMs technology to enable new therapies and address currently unmet medical needs.
- 网站
-
https://www.vesigen.com/
Vesigen Therapeutics, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Cambridge,Massachusetts
- 类型
- 私人持股
地点
-
主要
790 Memorial Dr
Suite 103
US,Massachusetts,Cambridge,02139
Vesigen Therapeutics, Inc.员工
-
Lorien Moore
Chief Operating Officer
-
Amanda Strout
Director, HR & Business Operations
-
Emmanuel Appiah
Biotechnology Professional | Research Associate | Expertise in Preclinical Immuno-Oncology, In Vivo, Ex Vivo Research, and PK/PD Analysis | Disease…
-
Nedyalka (Nelly) Valkov
RNA Therapeutics | Genome Editing | Drug Discovery | Non-Viral Delivery | Molecular Biology | Cardiac Biology and Disease
动态
-
Paulash Mohsen, CEO of Vesigen Therapeutics, Inc., discusses the company’s delivery technology, its advantages over viral vectors and liquid nanoparticles, and how they enable the targeting of previously undruggable targets. https://lnkd.in/gHWrUraF
-
-
Just one more day until Joe Nabhan will be speaking about our engineered #ARMMs platform at the Next Generation Gene Therapy Vectors Summit!
Our CSO, Joe Nabhan, will be speaking at the 4th?Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) about recent advances made to our engineered #ARMMs platform.
-
-
Did you know every 2 seconds someone in the US needs blood and/or platelets? 1 blood donation can save up to 3 lives! That's why we are hosting a mobile blood drive at our office on Tuesday July 16th from 9:00-2:30. There are plenty of spots available and it's open to the public. Our office is located at 790 Memorial Drive in Cambridge, MA. Help us give back to the community by signing up here: https://lnkd.in/eHzpK7nm
-
Did you know every 2 seconds someone in the US needs blood and/or platelets? 1 blood donation can save up to 3 lives! That's why we are hosting a mobile blood drive at our office on Tuesday July 16th from 9:00-2:30. There are plenty of spots available and it's open to the public. Our office is located at 790 Memorial Drive in Cambridge, MA. Help us give back to the community by signing up here: https://lnkd.in/eHzpK7nm
-
Just one more day until Joe Nabhan will be speaking about our engineered #ARMMs platform at the Next Generation Gene Therapy Vectors Summit!
Our CSO, Joe Nabhan, will be speaking at the 4th?Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) about recent advances made to our engineered #ARMMs platform.
-
-
Our CSO, Joe Nabhan, will be speaking at the 4th?Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) about recent advances made to our engineered #ARMMs platform.
-
-
I am excited to attend BIO International Convention next week from June 3-6 in San Diego, CA. Send me an invite in the partnering portal if you'd like to learn about Vesigen Therapeutics, Inc. non-viral delivery technology. #BIO2024 #nonviral #delivery #geneediting
-
-
That's a wrap on our time at #ARVO2024 and #ASGCT2024! Check out our press release at the link below for a recap of what was presented last week. https://lnkd.in/eb83Zxk7
-
-
Join us for our final presentations of #ASGCT2024 at 12:00 PM today!
-